Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer

Daniel D. Karp, Luis G. Paz-Ares, Silvia Novello, Paul Haluska, Linda Garland, Felipe Cardenal, L. Johnetta Blakely, Peter D. Eisenberg, Corey J. Langer, George Blumenschein, Faye M. Johnson, Stephanie Green, Antonio Gualberto

Research output: Contribution to journalArticlepeer-review

237 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences